GlobalData on MSN2d
EMA approves Bavarian Nordic’s mpox vaccine for teenagers
The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...
Medscape2d
Hympavzi Approved in Europe for Severe Hemophilia A and B
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...
FiercePharma2d
Europe's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and Henlius
Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...
EU extends authorization of the mpox vaccine to adolescents
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.
Medscape2d
EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.
Cambridge University Press2d
European Conquest and the Rights of Indigenous Peoples
Suzuki, Shogo 2005. Japan’s Socialization into Janus-Faced European International Society. European Journal of International Relations, Vol. 11, Issue. 1, p. 137. Te Ata O Tu MacDonald, Lindsey and ...
Le Lézard3d
Multi-sponsor Pregnancy Exposure Registries: Physician, Scientific Advisory and Industry Insights, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how pregnancy exposure registries are helping in assessing medication safety and thus enhance pregnancy safety studies. Attendees will learn about the historical context of ...